Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AIM ImmunoTech Inc.AIM · Entity 8131 | Director | March 14, 2025 | March 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AIM ImmunoTech Inc.
Report date March 14, 2025 · Filed March 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 291,882 |
Reported balance
After 2025-03-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-03-14 · Grant · Acquired 44,899 · Balance 291,882 F1: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2025 Filed Mar 18, 2025 21:10 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 44,899 | $0.12 | $5,208.28 |
DisclosureSEC source: 0001493152-25-010819 · ownership.xml · nonDerivative · entry 1 BRYAN NANCY · CIK 0001492613 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,882 F1 · balance_after: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 19:14 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 38,580 | $0.14 | $5,208.30 |
DisclosureSEC source: 0001493152-25-009013 · ownership.xml · nonDerivative · entry 1 BRYAN NANCY · CIK 0001492613 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,983 F1 · balance_after: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:20 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 43,330 | $0.12 | $5,208.27 |
DisclosureSEC source: 0001493152-25-007578 · ownership.xml · nonDerivative · entry 1 BRYAN NANCY · CIK 0001492613 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,403 F1 · balance_after: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 25,797 | $0.20 | $5,208.41 |
DisclosureSEC source: 0001493152-25-004670 · ownership.xml · nonDerivative · entry 1 BRYAN NANCY · CIK 0001492613 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,073 F1 · balance_after: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 27,412 | $0.19 | $5,208.28 |
DisclosureSEC source: 0001493152-25-002756 · ownership.xml · nonDerivative · entry 1 BRYAN NANCY · CIK 0001492613 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,276 F1 · balance_after: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:35 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 26,305 | $0.20 | $5,208.39 |
DisclosureSEC source: 0001493152-25-000269 · ownership.xml · nonDerivative · entry 1 BRYAN NANCY · CIK 0001492613 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,864 F1 · balance_after: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 22:00 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 24,452 | $0.21 | $5,208.28 |
DisclosureSEC source: 0001493152-24-050435 · ownership.xml · nonDerivative · entry 1 BRYAN NANCY · CIK 0001492613 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,559 F1 · balance_after: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 23:29 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 22,645 | $0.23 | $5,208.35 |
DisclosureSEC source: 0001493152-24-048533 · ownership.xml · nonDerivative · entry 1 BRYAN NANCY · CIK 0001492613 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,107 F1 · balance_after: These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 17:30 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | PurchaseCommon Stock | 38,462 | $0.39 | $15,000.18 |
DisclosureSEC source: 0001492613-24-000002 · primary_doc.xml · nonDerivative · entry 1 BRYAN NANCY · CIK 0001492613 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,462 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.